GlassScriptPhysician profile
Elmore J Becker
NPI 1396791372
$3,722.98
in general payments reported to CMS, 2019-2025
41 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $334 · 2021: $505 · 2022: $603 · 2023: $556 · 2024: $656 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $580.07 | 2019-2025 | Erleada |
| Pfizer INC. | $387.83 | 2019-2025 | |
| Astellas Pharma US INC | $350.61 | 2019-2024 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $349.95 | 2019-2025 | Rezum Generator, Wavewriter Alpha Prime 16 |
| Dendreon Pharmaceuticals LLC | $333.65 | 2019-2023 | Provenge |
| Blue Earth Diagnostics | $219.47 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $134.74 | 2024-2025 | Gemtesa |
| Laborie Medical Technologies Corp. | $95.92 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Alnylam Pharmaceuticals INC. | $84.49 | 2021-2023 | Givlaari |
| Axonics, INC. | $83.26 | 2022-2023 | Axonics |
| Merck Sharp & Dohme LLC | $80.47 | 2019-2025 | Zerbaxa, Lynparza |
| Urogen Pharma, INC. | $75.32 | 2020-2024 | Jelmyto |
| Sun Pharmaceutical Industries INC. | $66.29 | 2019-2024 | Yonsa |
| Abbvie INC. | $66.05 | 2019-2024 | |
| Tolmar Pharmaceuticals, INC. | $55.71 | 2019-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elmore Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.